Abstract
Recent developments in consumer access to drug information are reviewed. Technological changes, federal regulatory developments and changes in physician and pharmacist practices resulting from health care cost containment strategies, and changes in pharmaceutical industry practices toward providing drug information to consumers are highlighted and discussed. The resulting changes in the ability of consumers to make informed choices concerning health care and to make sound decisions in the use of prescription drugs are described. The role of the pharmaceutical company drug information department as a part of this process is critically evaluated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
